Device Trial Radar · NCT03320304
A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression.
Last checked: Nov 20, 2026Latest source record: Aug 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Dec 14, 2017
Primary completion
Dec 1, 2029
Study completion Dec 1, 2031
Sponsor
- Lead sponsor
- LivaNovaPublic (LIVN)
- Sponsor type
- Industry
- First posted
- Oct 25, 2017
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to assess short, mid and long-term clinical outcomes in patients with difficult to treat depression (such as patients with treatment resistant depression) treated with Vagus Nerve Stimulation (VNS) Therapy as adjunctive therapy.
Conditions
- Treatment Resistant Depression
Interventions
Vagal Nerve Simulation (VNS) TherapyDevice
A VNS Therapy System used for vagus nerve stimulation and consisting of an implantable VNS Therapy generator, lead, and external programming system.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary endpoint of this study is response defined as reduction in Montgomery Åsberg Depression Rating Scale (MADRS) total score of at least 50% from baseline to 12 months post implant.Time frame: 12 months
Locations
18 sites in 4 countries. Site status is shown where the registry gives one.
AKH Allgemeines Krankenhaus der Stadt Wien
Vienna, Austria · Recruiting
KU Leuven
Leuven, Belgium · Recruiting
Sozialstiftung Bamberg - Klinikum am Bruderwald
Bamberg, Germany · Withdrawn
15 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.